🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a monocentric, randomized, open-label, single-dose, three-cycle, pa...
Status
Completed
Location
Shanghai Xuhui Central Hospital
Start Date
2022-06-01
Trial ID
NCT05318820
Treatments Being Tested
This is an open-label, multicenter study to evaluate the safety, tolerabili...
Status
Withdrawn
Location
Childrens Hospital of California
Start Date
2024-04-02
Trial ID
NCT06291415
Treatments Being Tested
A Phase I, Open-label, Dose-escalation Study of the Safety and Pharmacokine...
Status
Completed
Location
BeijingCancer Hospital
Start Date
2016-12-27
Trial ID
NCT02857998
Treatments Being Tested
A Phase 1, Open-label, 4-Period, Randomized 6-Sequence Study to Evaluate th...
Status
Completed
Location
PPD Austin
Start Date
2022-07-13
Trial ID
NCT05571787
Treatments Being Tested
The purpose of this study is to determine whether HMPL-523 (sovleplenib) is...
Status
Completed
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2021-10-27
Trial ID
NCT05029635
This is a Phase I, open-label, multicenter study of HMPL-523 administered o...
Status
Terminated
Location
Pacific Cancer Medical Center, Inc.
Start Date
2019-09-26
Trial ID
NCT03779113
Treatments Being Tested
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
Nucleus Network Limited
Start Date
2014-05
Trial ID
NCT02105129
Two formulations containing the same active pharmaceutical ingredient are c...
Status
Completed
Location
The First Affiliated Hospital of Shandong First Medical University
Start Date
2025-10-28
Trial ID
NCT07331194
Treatments Being Tested
Phase II Study: To evaluate the safety and preliminary efficacy of HMPL-523...
Status
Active Not Recruiting
Location
Fuyang Hospital Of Anhui Medical University
Start Date
2022-09-30
Trial ID
NCT05535933
Treatments Being Tested
This is a Phase I, open-label, non-randomized, multicenter study to evaluat...
Status
Terminated
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Start Date
2018-10-09
Trial ID
NCT03483948
Treatments Being Tested